Baird Financial Group’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.49M | Buy |
13,089
+1,452
| +12% | +$165K | ﹤0.01% | 1102 |
|
|
2025
Q1 | $1.22M | Sell |
11,637
-65,570
| -85% | -$6.89M | ﹤0.01% | 1107 |
|
|
2024
Q4 | $8.27M | Buy |
77,207
+6,143
| +9% | +$658K | 0.02% | 557 |
|
|
2024
Q3 | $7.11M | Buy |
71,064
+14,287
| +25% | +$1.43M | 0.01% | 594 |
|
|
2024
Q2 | $4.78M | Buy |
56,777
+4,467
| +9% | +$376K | 0.01% | 678 |
|
|
2024
Q1 | $3.82M | Buy |
52,310
+12,835
| +33% | +$938K | 0.01% | 750 |
|
|
2023
Q4 | $2.82M | Sell |
39,475
-1,469
| -4% | -$105K | 0.01% | 833 |
|
|
2023
Q3 | $2.45M | Sell |
40,944
-2,422
| -6% | -$145K | 0.01% | 847 |
|
|
2023
Q2 | $3.13M | Buy |
43,366
+35,121
| +426% | +$2.53M | 0.01% | 776 |
|
|
2023
Q1 | $607K | Buy |
8,245
+4,684
| +132% | +$345K | ﹤0.01% | 1254 |
|
|
2022
Q4 | $238K | Sell |
3,561
-2,471
| -41% | -$165K | ﹤0.01% | 1544 |
|
|
2022
Q3 | $324K | Buy |
6,032
+104
| +2% | +$5.59K | ﹤0.01% | 1434 |
|
|
2022
Q2 | $330K | Buy |
5,928
+351
| +6% | +$19.5K | ﹤0.01% | 1508 |
|
|
2022
Q1 | $391K | Sell |
5,577
-77
| -1% | -$5.4K | ﹤0.01% | 1511 |
|
|
2021
Q4 | $545K | Sell |
5,654
-1,912
| -25% | -$184K | ﹤0.01% | 1440 |
|
|
2021
Q3 | $658K | Buy |
7,566
+1,481
| +24% | +$129K | ﹤0.01% | 1371 |
|
|
2021
Q2 | $498K | Sell |
6,085
-1,377
| -18% | -$113K | ﹤0.01% | 1398 |
|
|
2021
Q1 | $710K | Sell |
7,462
-239
| -3% | -$22.7K | ﹤0.01% | 1256 |
|
|
2020
Q4 | $478K | Sell |
7,701
-200
| -3% | -$12.4K | ﹤0.01% | 1238 |
|
|
2020
Q3 | $470K | Sell |
7,901
-2,321
| -23% | -$138K | ﹤0.01% | 1177 |
|
|
2020
Q2 | $713K | Buy |
10,222
+1,282
| +14% | +$89.4K | ﹤0.01% | 1045 |
|
|
2020
Q1 | $406K | Sell |
8,940
-2,597
| -23% | -$118K | ﹤0.01% | 1121 |
|
|
2019
Q4 | $751K | Sell |
11,537
-37,574
| -77% | -$2.45M | ﹤0.01% | 1059 |
|
|
2019
Q3 | $3.05M | Buy |
49,111
+1,015
| +2% | +$63K | 0.01% | 653 |
|
|
2019
Q2 | $3.43M | Buy |
+48,096
| New | +$3.43M | 0.01% | 624 |
|